-
EDITORIAL
The API process development time conundrum. Is scalable technology the solution?
O. Dapremont
-
ADVERTORIAL
Jiuzhou Pharmaceutical: Expert Full-Spectrum CDMO Solutions from Discovery to Delivery
-
FLOW CHEMISTRY
Organometallics in Flow: Scalable synthesis of Mg- and Zn-organometallics
G. Menges-Flanagan, E. Deitmann, L. Gössl
-
FLOW CHEMISTRY
The impact of flow chemistry in the drug discovery process
A. Mansfield
-
REPORT – 14th CFRT for Industrial Applications Symposium
-
Column: REGULATION
Artificial intelligence and toxicology/ risk assessment: the unknown future
A. Conto
-
HPAPIs
Containment Performance Assessment of a DPTE® Alpha Port
J. Ball, C. Mounier
-
COLUMN: API OF THE MONTH
Aprocitentan
R. Souza
-
FINE CHEMICALS
A patent landscape of ammonia industrial synthesis
M. Barbieri
-
PAT
PAT – Advancing innovation, efficiency and control in biopharma manufacturing
S. Shollenberger
-
BIOPROCESSING
A process digital twin framework for biopharmaceutical manufacturing
R. Wheaton, A. Munir, S. N. G. Gourisetti, C. Vanlang, H. Cui, T. Erdenberger, J. Shultz, B. To
-
PREPARATIVE CHROMATOGRAPHY
Preparative chromatography of peptides and other large molecules
S. McIntyre
-
EXCIPIENTS
How to mitigate nitrosamine risk with low nitrite excipients
E. Tocce
-
BIOSIMILARS
Flexibility and education keys to overcoming biosimilar barriers
C. K. Schneider
-
COLUMN: CLINICAL TRIALS CHALLENGES
Countdown: Time pressure for sponsors to move trials to the CTR
X. Neuberger
-
COLUMN: The M&A Catalyst
Reshaping the fine & specialty chemicals for a multipolar world
B. Comanita
-
COLUMN: The M&A Catalyst
Cash in on your hard work: dos and don’ts when selling your chemical business
J. V. Biege
-
PANEL DISCUSSION ON MERGERS & ACQUISITIONS
B. Comanita
